Literature DB >> 15836801

Blockade of beta-adrenergic receptors prevents amphetamine-induced behavioural sensitization in rats: a putative role of the bed nucleus of the stria terminalis.

Joyce Colussi-Mas1, Fany Panayi, Hélène Scarna, Bernard Renaud, Anne Bérod, Laura Lambás-Señas.   

Abstract

Recent findings have given evidence a role for noradrenergic transmission in the mechanisms underlying behavioural sensitization to psychostimulants. This work was undertaken to investigate the possible role of beta-adrenergic receptors in amphetamine-induced behavioural sensitization in rats. Rats were sensitized by a single administration of amphetamine (1 mg/kg s.c.) and challenged with the same dose 7 d later. The beta(1) /beta(2) -adrenergic receptor antagonists timolol (10 mg/kg i.p.) and nadolol (10 mg/kg i.p.), which respectively cross or do not readily cross the blood-brain barrier, were injected prior to the first or second amphetamine administration. Timolol, but not nadolol, prevented the initiation of behavioural sensitization without interfering with the expression of the sensitized response or the acute locomotor response to amphetamine. Since we found amphetamine-induced fos-activated cells closely associated with dopamine beta-hydroxylase immunoreactive varicosities in the bed nucleus of the stria terminalis (BNST), we investigated the effect of a bilateral micro-injection of timolol into this nucleus. Similarly to systemic administration, intra-BNST timolol (2.5 microg/side) prevented the development of behavioural sensitization. These results suggest that central beta-adrenergic receptors could specifically modulate early neuronal changes leading to the development of behavioural sensitization to psychostimulants, and that the BNST could be an important part of the brain circuitry involved in these long-term neuroadaptations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15836801     DOI: 10.1017/S1461145705005298

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  10 in total

1.  Norepinephrine mediates contextual fear learning and hippocampal pCREB in juvenile rats exposed to predator odor.

Authors:  Patricia A Kabitzke; Lindsay Silva; Christoph Wiedenmayer
Journal:  Neurobiol Learn Mem       Date:  2011-04-14       Impact factor: 2.877

2.  What is the bed nucleus of the stria terminalis?

Authors:  Eric C Dumont
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-07-12       Impact factor: 5.067

3.  Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine.

Authors:  Karen M Alsene; Katie Fallace; Vaishali P Bakshi
Journal:  Neuropsychopharmacology       Date:  2010-08-04       Impact factor: 7.853

4.  Stimulant use and bone health in US children and adolescents: analysis of the NHANES data.

Authors:  Yanan Fu; Guan Wang; Junhui Liu; Meng Li; Meng Dong; Chen Zhang; Rui Xu; Xinjie Liu
Journal:  Eur J Pediatr       Date:  2022-01-29       Impact factor: 3.183

Review 5.  Corticotropin releasing factor and norepinephrine related circuitry changes in the bed nucleus of the stria terminalis in stress and alcohol and substance use disorders.

Authors:  Angela E Snyder; Yuval Silberman
Journal:  Neuropharmacology       Date:  2021-10-06       Impact factor: 5.250

6.  Activation of afferents to the ventral tegmental area in response to acute amphetamine: a double-labelling study.

Authors:  Joyce Colussi-Mas; Stefanie Geisler; Luc Zimmer; Daniel S Zahm; Anne Bérod
Journal:  Eur J Neurosci       Date:  2007-08       Impact factor: 3.386

Review 7.  Biological treatments for amfetamine dependence : recent progress.

Authors:  Kevin P Hill; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 8.  Adrenaline rush: the role of adrenergic receptors in stimulant-induced behaviors.

Authors:  Karl T Schmidt; David Weinshenker
Journal:  Mol Pharmacol       Date:  2014-02-05       Impact factor: 4.436

9.  Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment.

Authors:  M P Mosti; G Flemmen; J Hoff; A K Stunes; U Syversen; E Wang
Journal:  Osteoporos Int       Date:  2015-10-26       Impact factor: 4.507

Review 10.  The Involvement of Norepinephrine in Behaviors Related to Psychostimulant Addiction.

Authors:  Magdalena Zaniewska; Małgorzata Filip; Edmund Przegalinski
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.